Document sans titre

News

14/03/2024 : 10ième symposium "Reins & Médicament" du CHR de Liège
Click here

17/03/2023 : Contrat d'intégration de RenAdaptor dans la base de données POSOS - France;
Click here

09/03/2023 : 9ième symposium "Reins & Médicament" du CHR de Liège
Click here

22/12/2022 : Signature d'un contrat exclusif de distribution avec la société Axilios
Click here

10/03/2022 : 8ième symposium "Reins & Médicament" du CHR de Liège
Click here

18/04/2021 : Creation of a new feature "Create a list" which now allows you to store a created list of medications.

12/03/2021 : Creation of a direct reference link to the PubMed directory for abstract reading.

31/10/2019 : First integrated version of Renadaptor in DelphiCare of the belgian pharmaceutical association (APB)
Click here

24/09/2019 : First institutional version of www.renadaptor.org proposed at the hospital CHR of Liège - Belgium

14/03/2019 : 7ième symposium "Reins & Médicament" du CHR de Liège
Click here

22/11/2024 : Zanidatamab
Click here

19/11/2024 : Revumenib
Click here

14/11/2024 : Obecabtagene autoleucel
Click here

07/11/2024 : Vorasidenib
Click here

06/11/2024 : Lifileucel
Click here

28/10/2024 : Marstacimab
Click here

26/10/2024 : Foslevodopa + Foscarbidopa
Click here Click here

23/10/2024 : Inavolisib
Click here

22/10/2024 : Zolbetuximab
Click here Click here

21/10/2024 : Arimoclomol
Click here

19/10/2024 : Levacetylleucine
Click here

28/08/2024 : Lazertinib
Click here

22/08/2024 : Axatilimab
Click here

22/08/2024 : Seladelpar
Click here

21/08/2024 : Nemolizumab
Click here

19/08/2024 : Efanesoctocog alfa
Click here Click here

17/08/2024 : Deuruxolitinib
Click here

17/08/2024 : Apadamtase alfa / ADAMTS13r
Click here Click here

17/08/2024 : : Fidanacogene elaparvovec
Click here

30/07/2024 : Benzgalantamine
Click here

09/07/2024 : Donanemab
Click here

01/07/2024 : Insulin Icodec
Click here

25/06/2024 : Crovalimab
Click here

22/06/2024 : Elafibranor
Click here

17/06/2024 : Imetelstat
Click here

30/05/2024 : Danicopan
Click here Click here

30/05/2024 : Aztreonam + Avibactam
Click here

17/05/2024 : Tarlatamab
Click here

04/05/2024 : Tovorafenib
Click here

04/05/2024 : Mavorixafor
Click here

20/04/2024 : Pegulicianine
Click here

30/03/2024 : Sotatercept
Click here

25/03/2024 : Givinostat
Click here

20/03/2024 : Aprocitentan
Click here

17/03/2024 : Resmetirom
Click here

12/03/2024 : Exagamglogene autotemcel
Click here

24/02/2024 : Cefepime + Enmetazobactam
Click here

30/01/2024 : Gadopiclenol
Click here

31/12/2023 : Palopegteriparatide
Click here

31/12/2023 : Pegzilarginase
Click here

30/12/2023 : Tabelecleucel
Click here

23/12/2023 : Eplontersen
Click here

09/12/2023 : Iptacopan
Click here

29/11/2023 : Nirogacestat
Click here

25/11/2023 : Lebrikizumab
Click here

22/11/2023 : Efbemalenograstim
Click here

21/11/2023 : Capivasertib
Click here

17/11/2023 : Repotrectinib
Click here

10/11/2023 : Fruquintinib
Click here

30/10/2023 : Toripalimab
Click here

27/10/2023 : Etrasimod
Click here

27/10/2023 : Vamorolone
Click here

21/10/2023 : Gefapixant
Click here

21/10/2023 : Zilucoplan
Click here

21/10/2023 : Itopride
Click here

16/10/2023 : Tislelizumab
Click here
07/10/2023 : Nedosiran
Click here
07/10/2023 : Gepirone
Click here
06/10/2023 : Motixafortide
Click here
22/09/2023 : Momelotinib
Click here
23/08/2023 : Avacincaptad pegol
Click here
23/08/2023 : Pegcetacoplan
Click here
22/08/2023 : Vadadustat
Click here
21/08/2023 : Pozelimab
Click here
21/08/2023 : Palovarotene
Click here
20/08/2023 : Elranatamab
Click here
19/08/2023 : Cipaglucosidase alfa
Click here
19/08/2023 : Miglustat
Click here
19/08/2023 : Levoketoconazole
Click here
17/08/2023 : Mirikizumab
Click here
13/08/2023 : Talquetamab
Click here
12/08/2023 : Zuranolone
Click here
24/07/2023 : Quizartinib
Click here
18/07/2023 : Glofitamab
Click here
15/07/2023 : Brolucizumab
Click here Click here
15/07/2023 : Faricimab
Click here Click here
05/07/2023 : Ranibizumab
Click here Click here
01/07/2023 : Rozanolixizumab
Click here
29/06/2023 : Ritlecitinib
Click here
25/06/2023 : Eflapegrastim
Click here
25/06/2023 : Sulbactam + Durlobactam
Click here
24/06/2023 : Pegunigalsidase alfa
Click here
24/06/2023 : Efgartigimod alfa + Hyaluronidase
Click here
22/05/2023 : Epcoritamab
Click here
20/05/2023 : Fezolinetant
Click here
27/04/2023 : Tofersen
Click here
18/04/2023 : Omidubicel
Click here
16/04/2023 : Rezafungin
Click here
10/04/2023 : Vilobelimab
Click here
30/03/2023 : Etranacogene dezaparvovec
Click here
25/03/2023 : Leniolisib
Click here
25/03/2023 : Retifanlimab
Click here
24/03/2023 : Trofinetide
Click here
14/03/2023 : Zavegepant
Click here
02/03/2023 : Omaveloxolone
Click here
23/02/2023 : Sparsentan
Click here
03/02/2023 : Daprodustat
Click here
30/01/2023 : Isoflurane
Click here Click here
28/01/2023 : Elacestrant
Click here
28/01/2023 : Pirtobrutinib
Click here
28/01/2023 : Bexagliflozin
Click here
28/01/2023 : Desflurane
Click here Click here
22/01/2023 : MEOPA / Nitrous oxide
Click here Click here
22/01/2023 : Sevoflurane
Click here Click here
08/01/2023 : Lecanumab
Click here

30/12/2022 : Ublituximab
Click here

30/12/2022 : Octreotide acetate (oral)
Click here

27/12/2022 : Fecal microbiota
Click here

13/12/2022 : Adagrasib
Click here

04/12/2022 : Olutasidenib
Click here

27/11/2022 : Sincalide
Click here

21/11/2022 : Teplizumab
Click here

19/11/2022 : Mirvetuximab soravtansine
Click here

28/10/2022 : Teclistamab
Click here

27/10/2022 : Tremelimumab
Click here

14/10/2022 : Futibatinib
Click here

14/10/2022 : Deucravacitinib
Click here

30/09/2022 : Phenylbutyrate Na + Taurursodiol
Click here

29/08/2022 : Lenacapavir
Click here

17/08/2022 : Eladocagene exuparvovec
Click here

02/08/2022 : Olipudase alfa
Click here

02/08/2022 : Atidarsagene autotemcel
Click here

12/07/2022 : Indigotindisulfonate Na
Click here

12/07/2022 : Linzagolix
Click here

11/07/2022 : Mosunetuzumab
Click here

17/06/2022 : Ciltacabtagene autoleucel
Click here    Click here

16/06/2022 : Vutrisiran
Click here

17/05/2022 : Vonoprazan
Click here

14/05/2022 : Roxadustat
Click here

14/05/2022 : Tirzepatide
Click here

01/05/2022 : Trientine 4HCl
Click here

01/05/2022 : Mavacamten
Click here

01/05/2022 : Oteseconazole
Click here

02/04/2022 : Lutetium Lu 177 vipivotide tetraxetan
Click here

22/03/2022 : Nivolumab + Relatlimab
Click here

20/03/2022 : Ganaxolone
Click here

20/03/2022 : Somatrogon
Click here
Click here

08/03/2022 : Pacritinib
Click here

18/02/2022 : Mitapivat
Click here

16/02/2022 : Bebtelovimab
Click here

16/02/2022 : Tixagevimab + Cilgavimab
Click here

16/02/2022 : Bamlanivimab + Etesevimab
Click here

15/02/2022 : Molnupiravir
Click here

14/02/2022 : Casirivimab + Imdevimab
Click here
Click here

14/02/2022 : Regdanvimab
Click here

14/02/2022 : Nirmatrelvir + Ritonavir
Click here
Click here

05/02/2022 : Sutimlimab
Click here

28/01/2022 : Tebentafusp
Click here

22/01/2022 : Abrocitinib
Click here

21/01/2022 : Sotrovimab
Click here

12/01/2022 : Daridorexant
Click here

23/12/2021 : Efgartigimod alfa
Click here

23/12/2021 : Tezepelumab
Click here

18/12/2021 : Budesonide delayed release
Click here

03/12/2021 : Pafolacianine
Click here

27/11/2021 : Maribavir
Click here

24/11/2021 : Nab-sirolimus
Click here

22/11/2021 : Vosoritide
Click here

06/11/2021 : Avacopan
Click here

31/10/2021 : Asciminib
Click here

18/10/2021 : Maralixibat
Click here

14/10/2021 : Atogepant
Click here

29/09/2021 : Tisotumab vedotin
Click here

19/09/2021 : Mobocertinib
Click here

31/08/2021 : Difelikefalin
Click here

29/08/2021 : Lonapegsomatropine
Click here

27/08/2021 : Bimekizumab
Click here

19/08/2021 : Belzutifan
Click here

19/08/2021 : Elivaldogene autotemcel
Click here

18/08/2021 : Avalglucosidase alfa
Click here

03/08/2021 : Anifrolumab
Click here

27/07/2021 : Odevixibat
Click here

26/07/2021 : Tralokinumab
Click here

17/07/2021 : Belumosudil
Click here

14/07/2021 : Idecabtagene vicleucel
Click here

14/07/2021 : Brincidofovir
Click here

13/07/2021 : Finerenone
Click here

13/07/2021 : Fosdenopterin
Click here

12/07/2021 : Ibrexafungerp
Click here

12/07/2021 : Olanzapine + Samidorphan
Click here

08/06/2021 : Aducanumab
Click here

31/05/2021 : Sotorasib
Click here

31/05/2021 : Infigratinib
Click here

29/05/2021 : Relugolix + Estradiol + Norethisterone / Norethindrone
Click here

26/05/2021 : Amivantamab
Click here

18/05/2021 : Pegcetacoplan
Click here

07/05/2021 : Citrate K + Bicarbonate K
Click here

28/04/2021 : Loncastuximab tesirine
Click here

25/04/2021 : Dostarlimab
Click here    Click here

18/04/2021 : Estetrol + Drospirenone
Click here    Click here

05/04/2021 : Viloxazine ER
Click here

27/03/2021 : Dasiglucagon
Click here

25/03/2021 : Ponesimod
Click here

14/03/2021 : Melphalan flufenamide
Click here

06/03/2021 : Brexucabtagene autoleucel
Click here
Click here

06/03/2021 : Casimersen
Click here

05/03/2021 : Serdexmethylphenidate + Dexmethylphenidate
Click here

26/02/2021 : Lisocabtagene maraleucel
Click here

20/02/2021 : Trilaciclib
Click here

19/02/2021 : Evinacumab
Click here

12/02/2021 : Umbralisib
Click here

12/02/2021 : Tepotinib
Click here

30/01/2021 : Voclosporin
Click here

29/01/2021 : Cabotegravir
Click here

29/01/2021 : Rilpivirine IM
Click here

25/01/2021 : Inclisiran
Click here

24/01/2021 : Vericiguat
Click here

24/01/2021 : Berotralstat
Click here

24/01/2021 : Ansuvimab
Click here

24/01/2021 : Margetuximab
Click here

28/12/2020 : Vibegron
Click here

19/12/2020 : Relugolix
Click here

07/12/2020 : Setmelanotide
Click here

02/12/2020 : Lumasiran
Click here

29/11/2020 : Naxitamab
Click here

28/11/2020 : Lonafarnib
Click here

18/11/2020 : Filgotinib
Click here

18/11/2020 : Imlifidase
Click here

17/10/2020 : Atoltivimab + Maftivimab + Odesivimab
Click here

07/09/2020 : Somapacitan
Click here

18/08/2020 : Satralizumab
Click here

14/08/2020 : Bulevirtide
Click here

14/08/2020 : Viltolarsen
Click here

12/08/2020 : Risdiplam
Click here

12/08/2020 : Oliceridine
Click here

12/08/2020 : Belantamab mafodotin
Click here

11/08/2020 : Tafasitamab
Click here

21/07/2020 : Decitabine + Cedazuridine
Click here

21/07/2020 : Betibeglogene autotemcel
Click here

08/07/2020 : Remdesivir
Click here

06/07/2020 : Fostemsavir
Click here

04/07/2020 : Remimazolam
Click here

30/06/2020 : Fenfluramine
Click here

23/06/2020 : Lurbinectedin
Click here

22/06/2020 : Inebilizumab
Click here

10/06/2020 : Onasemnogene abeparvovec
Click here

Click here

27/05/2020 : Daratumumab + Hyaluronidase
Click here

19/05/2020 : Ripretinib
Click here

13/05/2020 : Selpercatinib
Click here

09/05/2020 : Capmatinib
Click here

01/05/2020 : Monomethyl fumarate
Click here

30/04/2020 : Sacituzumab Govitecan
Click here

22/04/2020 : Pemigatinib
Click here

21/04/2020 : Tucatinib
Click here

14/04/2020 : Selumetinib
Click here

01/04/2020 : Ferric pyrophosphate citrate
Click here

29/03/2020 : Ozanimod
Click here

04/03/2020 : Osilodrostat
Click here

03/03/2020 : Isatuximab
Click here

02/03/2020 : Eptinezumab
Click here

02/03/2020 : Rimegepant
Click here

26/02/2020 : Bempedoic acid
Click here

27/01/2020 : Tazemetostat
Click here

23/01/2020 : Teprotumumab
Click here

13/01/2020 : Avapritinib
Click here

27/12/2019 : Lumateperone
Click here

27/12/2019 : Lemborexant
Click here

26/12/2019 : Enfortumab vedotin
Click here

24/12/2019 : Trastuzumab Deruxtecan
Click here

24/12/2019 : Ubrogepant
Click here

24/12/2019 : Levamlodipine
Click here

16/12/2019 : Golodirsen
Click here

26/11/2019 : Voxelotor
Click here

25/11/2019 : Cenobamate
Click here

21/11/2019 : Givosiran
Click here

18/11/2019 : Crizanlizumab
Click here

18/11/2019 : Cefiderocol
Click here

15/11/2019 : Zanubrutinib
Click here

11/11/2019 : Luspatercept
Click here

03/11/2019 : Diroximel fumarate
Click here

23/10/2019 : Elexacaftor + Tezacaftor + Ivacaftor
Click here

18/10/2019 : Lasmiditan
Click here

13/10/2019 : Levodopa (inhalation)
Click here
Click here

23/09/2019 : Semaglutide (oral)
Click here

07/09/2019 : Istradefylline
Click here

05/09/2019 : Lefamulin
Click here

04/09/2019 : Fedratinib
Click here

30/08/2019 : Entrectinib
Click here

29/08/2019 : Pretomanid
Click here

28/08/2019 : Upadacitinib
Click here

13/08/2019 : L-Arginine + L-Lysine
Click here

05/08/2019 : Pexidartinib
Click here

01/08/2019 : Darolutamide
Click here

19/07/2019 : imipenem + cilastatin + relebactam
Click here

19/07/2019 : Pentosan polysulfate sodium
Click here

Click here

05/07/2019 : Selinexor
Click here

24/06/2019 : Zanamivir IV
Click here

24/06/2019 : Bremelanotide
Click here

23/06/2019 : Polatuzumab vedotin
Click here

21/06/2019 : Ropeginterferon alfa-2b
Click here

21/06/2019 : Volanesorsen
Click here

21/06/2019 : Sotagliflozin
Click here

26/05/2019 : Alpelisib
Click here

29/04/2019 : Risankizumab
Click here

14/04/2019 : Erdafitinib
Click here

12/04/2019 : Romosozumab
Click here

29/03/2019 : Solriamfetol
Click here

29/03/2019 : Siponimod
Click here

28/03/2019 : Phendimetrazine tartrate
Click here

28/03/2019 : Testosterone undecanoate
Click here

23/03/2019 : Brexanolone
Click here

22/03/2019 : Curcuma longa
Click here

23/03/2019 : Macimorelin
Click here

20/03/2019 : Fexinidazole
Click here

15/03/2019 : Esketamine
Click here

05/03/2019 : Trastuzumab hyaluronidase
Click here

27/02/2019 :Turoctocog alfa pegol
Click here

Cancer therapy in patients with reduced kidney function.
Karam S, et al. NDT 2024 Dec.
Click here
Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in patients on chronic dialysis: a nationwide registry study.
Laville SM, et al. NDT. 2024 Oct.
Click here
Aging and chronic kidney disease: epidemiology, therapy, management and the role of immunity.
Tang Y, et al. CKJ. 2024 Sep.
Click here
AKI Associated with Anti-cancer Therapies: Small Molecules and Targeted Therapies.
Kala J, et al. Kidney360. 2024 Aug 26.
Click here
Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review
Wing SM, et al. Semin Nephrol. 2024 May 14.
Click here
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
Simms-Williams N, et al. BMJ. 2024 Apr 25.
Click here
Renal drug dosage adjustments and adverse drug events in patients with chronic kidney disease admitted to the hospital: a cross-sectional study.
Očovská Z, et al. Expert Opin Drug Saf. 2024 Feb 8.
Click here
Glomerular hyperfiltration as a therapeutic target for CKD.
Kanbay M, et al. NDT 2024 Feb 02.
Click here
Toxic Nephropathies of the Tubulointerstitium: Core Curriculum 2024.
Krishnan N, et al. AJKD 2024 Jan 19.
Click here

Advances in the management of chronic kidney disease.
Chen TK, et al. BMJ. 2023 Dec 05.
Click here
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor.
Liabeuf S, et al. CKJ. 2023 Dec.
Click here
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.

Hafez G, et al. CKJ. 2023 Dec.
Click here
Antiobesity Pharmacotherapy in Adults with Chronic Kidney Disease.
Taber-Hight E, et al. Kidney Int. 2023 Nov 03.
Click here
Kidney Stone Pathophysiology, Evaluation and Management: Core Curriculum 2023
Shastri S, et al. AJKD 2023 Aug 09.
Click here
Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial.
Collins MG, et al. Lancet 2023 Jun 16.
Click here
Atrial Fibrillation in Kidney Failure: Challenges in Risk Assessment and Anticoagulation Management
Law MM, et al. Kidney Med. 2023 Jun 19.
Click here
Combination Diuretic Therapy to Counter Renal Sodium Avidity in Acute Heart Failure: Trials and Tribulations.
Kazory A. CJASN 2023 Apr 27.
Click here
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Dhayat NA, et al. NEJM 2023 Mar 02.
Click here
Cystatin C–Based Equation to Estimate GFR without the Inclusion of Race and Sex.
Hans Pottel et al. NEJM 2023 Jan 26.
Click here

Prise en charge de la carence martiale au cours de la maladie rénale chronique : mise au point et proposition d'un algorithme [Management of iron deficiency in chronic kidney disease: Review and proposed algorithm].
Guibergia C, et al. Nephrol Ther. 2022 Dec.
Click here

Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group. NEJM Nov 04.
Click here

Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease
Bhandari S, et al. NEJM Nov 03.
Click here

Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
de Boer IH, et al. Kidney Int. 2022 Sep.
Click here

Use of Glucose-Lowering Agents in Diabetes and Chronic Kidney Disease.
Alicic RZ, et al. KIRep. 2022 Sep.
Click here

Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
Mullens W, et al. NEJM 2022 Aug.
Click here

Antifibrotic Agents for the Management of CKD: A Review.
Ruiz-Ortega M, et al. AJKD. 2022 Aug.
Click here

Management of Metabolic Acidosis in Chronic Kidney Disease: Past, Present, and Future Direction
Goraya N, et al. ACKD 2022 Jul.
Click here

European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and Haemostasis.
Eller K, et al. NDT. 2022 Jul.
Click here

Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022.
Hahr AJ, et al. AJKD. 2022 May.
Click here

Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials.
Xu C, et al. JASN 2022 May.
Click here

Gliflozins in the Management of Cardiovascular Disease.
Braunwald E. NEJM May 26.
Click here

Principles of Immunosuppression in the Management of Kidney Disease: Core Curriculum 2022.
Kant S, et al. AJKD 2022 Apr 16.
Click here

The Drug-Induced Acute Kidney Injury.
Perazella MA et al. CJASN 2022 Mar 10.
Click here

The rational use of complement inhibitors in kidney diseases.
Fakhouri F, et al. KIRep. 2022 Mar 04.
Click here

Diuretics in States of Volume Overload: Core Curriculum 2022.
Novak JE, et al. AJKD 2022 Feb 18
Click here

Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
Agarwal R, et al. NEJM. 2021 Dec 30.
Click here

High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis.
Petrie MC, et al. Cardiovasc Res. 2021 Dec 07.
Click here

New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.
Inker LA, et al. NEJM. 2021 Nov 4.
Click here

Chronic Kidney Disease-Associated Pruritus: A Review.
Makar M, et al. Kidney Blood Press Res. 2021 Sep 07.
Click here

Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review.
Ginsberg C, et al. AJKD. 2021 Aug 19.
Click here

The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation.
Harel Z, et al. CJASN 2021 Aug 18.
Click here

Principles of Kidney Pharmacotherapy for the Nephrologist: Core Curriculum 2021
Vondracek sF, et al. AJKD Jul 16
Click here

Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Hall RK et al. AJKD 2021 May.
Click here

A Clinician's Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement Therapy.
Bouajram RH, et al. KIRep. 2021 May.
Click here

International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.
Hayward S, et al. NDT. 2021 Mar.
Click here

Post-Dialysis Parenteral Antimicrobial Therapy in Patients Receiving Intermittent High-Flux Hemodialysis.
Cimino C, et al. Drugs. 2021 Apr.
Click here

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.
KDIGO Blood Pressure Work Group. Kidney Int. 2021 Mar.
Click here

Management of acute kidney injury in symptomatic multiple myeloma.
Bridoux F, et al. Kidney Int. 2021 Jan 09.
Click here

A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes.
Hultin S, et al. KIRep. 2020 Dec 30.
Click here

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
Murakami N et al. Kidney Int. 2020 Dec 23.
Click here

Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials.
Gencer B, et al. Lancet. 2020 Nov 21.
Click here

Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
Arnold F, et al. BMC Nephrol. 2020 Nov.
Click here

Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease.
Shavadia JS, et al. Am Heart J. 2020 Oct.
Click here

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer.
Porta C, et al. Kidney Int. 2020 Nov.
Click here

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Packer M, et al. NEJM. 2020 Oct 8.
Click here

Dapagliflozin in Patients with Chronic Kidney Disease.
Heerspink HJL, et al. NEJM 2020 Oct 08.
Click here

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Tuttle KR, et al. AJKD. 2020 Oct.
Click here

KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
KDIGO Diabetes Work Group. Kidney Int. 2020 Oct.
Click here

Treatment Options for COVID-19 in Patients with Reduced or Absent Kidney Function.
Miller-Handley H, Luckett K, Govil A. ACKD 2020 Sep 17.
Click here

Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
Hundemer GL, et al. AJKD 2020 Sep 11.
Click here

Medication Reconciliation: The Foundation of Medication Safety for Patients Requiring Dialysis.
Frament J, et al. AJKD. 2020 Sep 10.
Click here

Cystinuria: clinical practice recommendation.
Servais A, et al. Kidney Int. 2020 Sep 09.
Click here

Pathophysiology and Treatment of Enteric Hyperoxaluria.
Witting C, et al. CJASN 2020 Sep 08.
Click here

Pharmacological interventions for the prevention of renal injury in surgical patients: a systematic literature review and meta-analysis.
Pathak S, et al. BJA 2020 Aug 19.
Click here

The link between kidney disease and cancer: complications and treatment.
Malyszko J, et al. Lancet 2020 Jul 25.
Click here

Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.
Shaman AM, et al. CJASN 2020 Jul 18.
Click here

Adverse Drug Reactions in Patients with CKD.
Laville SM, et al. CJASN 2020 Jul 01.
Click here

Urate-Lowering Therapy and Chronic Kidney Disease Progression.
Feig DI. NEJM 2020 Jun 25.
Click here

Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.
Li J,et al. CJASN 2020 Jun 9.
Click here

NSAIDs in CKD: Are They Safe?
Baker M, et al. AJKD 2020 May 29.
Click here

How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion.
Maggiore U, et al. NDT 2020 May 22.
Click here

Breastfeeding and Medication Use in Kidney Disease.
Singh M. ACKD. 2020 May 10.
Click here

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
Danser AHJ, et al. Hypertension. 2020 Mar 25.
Click here

Proton Pump Inhibitors and the Kidney : Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.
Al-Aly Z, et al. AJKD 2020 Apr.
Click here

Toxicology for Nephrologists.
Harbord N. ACKD. 2020 Jan.
Click here

Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment.
Batchelor EK, et al. JASN 2020 Feb.
Click here

Therapeutic management of HIV-infected patients with chronic kidney disease.
Alfano G, et al. J Nephrol. 2020 Feb.
Click here

Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines.
Kelly DM, et al. Kidney Int. 2020 Feb.
Click here

The role of SGLT2 inhibitors in the management of chronic kidney disease. Metabolic and cardiorenal protective effects of SGLT2 inhibitors.
Heerspink HJL et al. NDT suppl. 2020 Jan
Click here

Medications Used Routinely in Primary Care to be Dose-Adjusted or Avoided in People With Chronic Kidney Disease: Results of a Modified Delphi Study.
Taji L, et al. Ann Pharmacother. 2020 Jan.
Click here

Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An Analysis of the CURE-CKD Registry.
Tuttle KR, et al. JAMA Netw Open. 2019 Dec.
Click here

Mineralocorticoid receptor antagonists in heart failure patients with chronic kidney disease: why, when, and how?
Kassem H, et al. Curr Opin Nephrol Hypertens 2019 Dec.
Click here

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study.
Heerspink HJL, et al. Lancet Diabetes Endocrinol. 2020 Jan.
Click here

Evolution of renal function under direct-acting antivirals treatment for chronic hepatitis C: A real-world experience.
Tsai MC, et al. J Viral Hepat. 2019 Dec.
Click here

Contraception and CKD.
Burgner A, et al. CJASN. 2019 Nov.
Click here

Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.
Peerapornratana S,et al. Kidney Int. 2019 Nov.
Click here

Safe and Effective Management of Pain in People with CKD.
Davison SN, et al. CJASN 2019 Nov.
Click here

Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
Suchard MA et al. Lancet. 2019 Oct 24.
Click here

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.
Neuen BL,et al. Lancet Diabetes Endocrinol. 2019 Nov.
Click here

Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
Best LM, et al. Cochrane Database Syst Rev. 2019 Sep.
Click here

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
Gordon CE,et al. Ann Intern Med. 2019 Sep.
Click here

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Kristensen SL, et al. Lancet Diabetes Endocrinol. 2019 Oct.
Click here

Extracorporeal Removal of Poisons and Toxins.
King JD, et al. CJASN. 2019 Aug.
Click here

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.
Dave CV, et al. Ann Intern Med. 2019 Jul.
Click here

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.
Wang Y, et al. JAMA Oncol. 2019 Jul.
Click here

Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Ha JT, et al. Ann Intern Med. 2019 Jul 16.
Click here

EASL Clinical Practice Guidelines: Drug-induced liver injury.
European Association for the Study of the Liver. J Hepatol. 2019 Jun.
Click here

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors.
Centanni M, et al. Clin Pharmacokinet. 2019 Jul.
Click here

Sodium-glucose cotransporter inhibitors: beyond glycaemic control.
Vergara A, et al. CKJ 2019 Jun.
Click here

Anticoagulant-related nephropathy: systematic review and meta-analysis.
de Aquino Moura KB, et al. CKJ 2019 Jun.
Click here

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fervenza FC, et al. NEJM 2019 Jul 4.
Click here

Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease
Sise ME, et al. Kidney Int. 2019 May 15.
Click here

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, et al. NEJM. 2019 Jun 13.
Click here

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.
Mosenzon O, et al. Lancet Diabetes Endocrinol. 2019 Jun.
Click here

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.
Charytan DM, et al. JACC 2019 Jun.
Click here

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
House AA, et al. Kidney Int. 2019 Jun.
Click here

Contrast-Associated Acute Kidney Injury.
Mehran R, et al. NEJM 2019 May 30.
Click here

Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled Trials.
Vogt L, et al. JAHA 2019 May.
Click here

Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Assimon MM, et al. JASN 2019 Apr.
Click here

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference.
Cheung AK, et al. for Conference Participants. Kidney Int. 2019 May.
Click here

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Villanueva C, et al. Lancet. 2019 Apr 20.
Click here

New pharmacological strategies for protecting kidney function in type 2 diabetes.
Muskiet MHA, et al. Lancet Diabetes Endocrinol. 2019 May.
Click here

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, et al. for the CREDENCE Trial Investigators. NEJM 2019 Apr 14.
Click here

Clinical Pharmacology in Diuretic Use.
Ellison DH. CJASN 2019 Apr 1.
Click here

Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.
Krens SD, et al. Lancet Oncol. 2019 Apr.
Click here

The safety of mineralocorticoid antagonists in maintenance hemodialysis patients: two steps forward.
Rossignol P, et al. Kidney Int. 2019 Apr.
Click here

Management of Hypertension in Chronic Kidney Disease.
Dan Pugh, et al. Drugs 2019 Mar.
Click here

Combination Therapy as First-Line Treatment in Metastatic Renal-Cell Carcinoma.
Escudier B. NEJM 2019 Mar 21.
Click here

Antibiotic Dosing in Chronic Kidney Disease and End-Stage Renal Disease: A Focus on Contemporary Challenges.
Vilay AM. ACKD. 2019 Jan.
Click here

Clinical Pharmacology of Antibiotics.
Eyler RF, et al. CJASN March 2019.
Click here

Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure.
Davison SN. Clin J Am Soc Nephrol. 2019 Mar 4.
Click here

Special Issue:Hepatitis C Virus Infection in Patients with Kidney Disease: A Roadmap for Nephrologists.
Semin Dial. 2019 Mar/Apr;32(2):89-197.
Click here

Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.
Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Lancet. 2019 Feb 23;3(10173):768-77.
Click here

Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities.
Estrada CC, Maldonado A, Mallipattu SK. J Am Soc Nephrol. 2019 Feb;30(2):187-200.
Click here

Once-Daily Plazomicin for Complicated Urinary Tract Infections.
Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Dwyer JP; EPIC Study Group. N Engl J Med. 2019 Feb 21;380(8):729-740.
Click here

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.
Sarafidis P, et al. Nephrol Dial Transplant. 2019 Feb 1;34(2):208-230.
Click here

14/03/2024 : Pharmacologie des médicaments et fenêtre thérapeutique
Click here

14/03/2024 : Les intoxications médicamenteuses vues aux urgences : les petites nouvelles
Click here

14/03/2024 : Reins & Médicaments toxiques
Click here

23/11/2023 : La juste prescription pour l’insuffisance rénale et la dialyse. Un outil indispensable : RenAdaptor.
Click here

15/06/2023 : Bénéfices des anti diabétiques au niveau cardio-vasculaire en 2023
Click here

15/06/2023 : Prise en charge multi-cible du patient diabétique : de la théorie à la pratique
Click here

05/06/2023 : La juste prescription pour l'insuffisance rénale et la dialyse: RenAdaptor.
Click here

09/03/2023 : Place de la pharmacie clinique pour réduire les erreurs de prescription en milieu hospitalier.
Click here

09/03/2023 : Polymédication et erreurs de prescription en gériatrie : comment y remédier ?
Click here

09/03/2023 : Fonds des Accidents Médicaux : Sinistres liés à des erreurs de prescription.
Click here

10/11/2022 : La révolution des gliflozines en néphrologie.
Click here

10/11/2022 : Règles de bases de néphroprotection en 2022.
Click here

16/06/2022 : SGLT2i ou la révolution néphrologique du XXIème siècle ?
Click here

16/06/2022 : Traiter le diabète de type 2 et réduire le risque cardio-vasculaire et rénal: mode d'emploi en 2022
Click here

16/06/2022 : La révolution des Inhibiteurs du SGLT2 pour les patients cardiaques
Click here

28/04/2022 : Two medications I would actively stop in elderly patients
Click here

10/03/2022 : Mesure et estimation du DFG pour un usage clinique en 2022
Click here

10/03/2022 : Impact de la bonne évaluation du DFG sur la prescription des médicaments.
Click here

10/03/2022 : Adaptation posologique lors d'une insuffisance rénale : Les cas du diabète et du cancer.
Click here

21/09/2021 : iSGLT2 et reins
Click here

16/03/2021 : Reins et sénescence
Click here

23/03/2020 : COVID-19, Plaquenil et Insuffisance rénale
Click here

12/12/2019 : La juste prescription pour l'insuffisance rénale et la dialyse : Renadaptor
Click here

14/03/2019 : IPP et reins font-ils bon ménage ?
Click here

14/03/2019 : Hepatitis C Virus Infection in Patients with Chronic Kidney Disease
Click here

14/03/2019 : L'axe Reins - Microbiote
Click here

06/12/2018 : La grippe en 2018 - 2019
      Dr. Benoit Pirotte
      Click here

      Dr. Filip Moerman
       Click here

01/12/2018 : Nouveautés diagnostiques et thérapeutiques en néphrologie : Une décennie riche en avancées.
Click here

21/06/2018 : Propriétés néphroprotectrices des nouveaux anti-dabétiques oraux (ADO)
Click here

02/06/2018 : Anticoagulation et Insuffisance Rénale
Click here

18/04/2018 : Traitements de l'ostéoporose chez l'insuffisant rénal chronique.
Click here

08/03/2018 : Particularités pharmacologiques de la personne âgée
Click here

08/03/2018 : Cibles Cardio-Vasculaires chez les plus de 75 ans.
Click here

08/03/2018 : Polymédication chez la personne âgée
Click here

12/12/2017 : Polykystose Rénale Autosomique Dominante (PKRAD): Avancées thérapeutiques récentes
Click here

04/12/2017 : La prise en charge des patients séropositifs pour le VIH en 2017
Click here

25/11/2017 : Diagnostic et prévention de la lithiase rénale récidivante
Click here

09/03/2017 : Approche thérapeutique en oncologie: Le point de vue de l'oncologue.
Click here

09/03/2017 : Mélanome métastatique - Thérapies ciblées / Immunothérapies
Click here

09/03/2017 : Ajustement des traitements anticancéreux à l'insuffisance rénale - L'importance d'être précis
Click here

09/03/2017 : Toxicité rénale des traitements en oncologie: Focus sur les nouvelles thérapies
Click here


RENADAPTOR : Videos




Document sans titre